Horizon Pharma (HZNP) Granted Additional USPTO Notice of Allowance With Claims Covering VIMOVO Delayed Release Tablets Mar 30, 2017 07:11AM
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO® (naproxen/esomeprazole) Delayed Release Tablets Mar 30, 2017 07:00AM
Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) to Ring The Nasdaq Stock Market Closing Bell Feb 13, 2017 10:00AM
Pre-Open Stock Movers 10/04: (SMMT) (SDRL) (ARLZ) Higher; (TRIB) (IRMD) (TWTR) Lower (more...) Oct 4, 2016 09:22AM
Horizon Pharma (HZNP) Receives USPTO Notice of Allowance on Patent Related to VIMOVO Jun 1, 2016 07:08AM


Jun 1, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Mar 14, 2016 07:19AM Horizon Pharma (HZNP) Receives USPTO Notice of Allowance for VIMOVO-Related Patent
Mar 14, 2016 07:00AM Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Feb 12, 2016 10:00AM Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) to Ring The Nasdaq Stock Market Closing Bell